NAOMI TORRES: Open Payments
NPI 1437589215 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,799 in 55 payments from 23 companies in 2025. Trend: 2023 $265 · 2024 $896 · 2025 $1,799
Food & beverage: $1,371Education: $428
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $391 |
| SEAGEN INC. | 2 | $174 |
| Tactile Systems Technology Inc | 2 | $144 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 5 | $122 |
| Novartis Pharmaceuticals Corporation | 4 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $102 |
| Eisai Inc. | 4 | $89 |
| Merck Sharp & Dohme LLC | 3 | $72 |
| TAIHO ONCOLOGY, INC. | 3 | $66 |
Products named: ENHERTU, Flexitouch Plus, Vyloy, Lenvima, NINLARO, LONSURF, PLUVICTO, ERLEADA.
Industry payments across NY — which companies pay providers there.
